Search

Your search keyword '"Erdmann, Joris I"' showing total 148 results

Search Constraints

Start Over You searched for: Author "Erdmann, Joris I" Remove constraint Author: "Erdmann, Joris I"
148 results on '"Erdmann, Joris I"'

Search Results

101. A nationwide assessment of hepatocellular adenoma resection: Indications and pathological discordance.

102. Factors associated with failure to rescue after liver resection and impact on hospital variation: a nationwide population-based study

104. Surgical outcomes of laparoscopic and open resection of benign liver tumours in the Netherlands: a nationwide analysis

105. Perihilar Cholangiocarcinoma – Novel Benchmark Values for Surgical and Oncological Outcomes From 24 Expert Centers

106. Actual 10-Year Survival after Resection of Perihilar Cholangiocarcinoma:What Factors Preclude a Chance for Cure?

107. Surgical outcomes of laparoscopic and open resection of benign liver tumours in the Netherlands:a nationwide analysis

108. Actual 10-year survival after resection of perihilar cholangiocarcinoma:What factors preclude a chance for cure?

109. The Role of CT in Assessment of Extraregional Lymph Node Involvement in Pancreatic and Periampullary Cancer: A Diagnostic Accuracy Study

110. ASO Author Reflections: Nationwide Experience on Locally Advanced Pancreatic Cancer Surgery After Induction Chemotherapy in the Netherlands: A Stepping Stone for the PREOPANC-4 Trial.

111. Hypothermic Machine Perfusion in Liver Transplantation — A Randomized Trial

113. Observational Study Occurrence of seeding metastases in resectable perihilar cholangiocarcinoma and the role of low-dose radiotherapy to prevent this

114. How to Approach Para-Aortic Lymph Node Metastases During Exploration for Suspected Periampullary Carcinoma: Resection or Bypass?

115. Should jaundice preclude resection in patients with gallbladder cancer? Results from a nation-wide cohort study

116. The Role of CT in Assessment of Extraregional Lymph Node Involvement in Pancreatic and Periampullary Cancer: A Diagnostic Accuracy Study

117. Presentation, Management and Outcome of Cholangiocarcinoma in Europe: Results From Real-World Patient Registry

118. TIGIT and PD1 Co-blockade Restores ex vivo Functions of Human Tumor-Infiltrating CD8+ T Cells in Hepatocellular Carcinoma

120. Occurrence of seeding metastases in resectable perihilar cholangiocarcinoma and the role of low-dose radiotherapy to prevent this

121. Resectability and Ablatability Criteria for the Treatment of Liver Only Colorectal Metastases: Multidisciplinary Consensus Document from the COLLISION Trial Group

122. Comparison of functional and volumetric increase of the future remnant liver and postoperative outcomes after portal vein embolization and complete or partial associating liver partition and portal vein ligation for staged hepatectomy (ALPPS)

123. Nationwide treatment and outcomes of perihilar cholangiocarcinoma.

124. Preoperative radiochemotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer (PREOPANC trial): study protocol for a multicentre randomized controlled trial.

125. Type I Interferons in the Treatment of Pancreatic Cancer

126. Diagnosis and treatment of patients with suspected mucinous cystic neoplasms of the liver: a retrospective cohort study.

127. A bile-based microRNA signature for differentiating malignant from benign pancreaticobiliary disease.

128. Lesions hyper- to isointense to surrounding liver in the hepatobiliary phase of gadoxetic acid-enhanced MRI.

129. Hypothermic Machine Perfusion in Liver Transplantation - A Randomized Trial.

130. Gemcitabine-cisplatin induction treatment in patients with locally advanced perihilar cholangiocarcinoma (IMPACCA): A prospective registration study.

131. Outcome of a 'step-up approach' for recurrent cholangitis in patients with a non-stenotic hepaticojejunostomy after hepato-pancreato-biliary surgery: single center series.

132. Comparing Survival of Perihilar Cholangiocarcinoma After R1 Resection Versus Palliative Chemotherapy for Unresected Localized Disease.

133. The effect of liver surgery and fluid strategy on renin activity and aldosterone and anti-diuretic hormone levels: a secondary analysis of the GALILEO trial.

134. Towards a 'step-up approach' for the treatment of recurrent non-stenotic cholangitis after hepaticojejunostomy: systematic review.

135. Surgery for Locally Advanced Pancreatic Cancer Following Induction Chemotherapy: A Single-Center Experience.

136. Healthcare cost expenditure for robotic versus laparoscopic liver resection: a bottom-up economic evaluation.

137. Higher Postoperative Mortality and Inferior Survival After Right-Sided Liver Resection for Perihilar Cholangiocarcinoma: Left-Sided Resection is Preferred When Possible.

138. Robotic Versus Open Hepatic Arterial Infusion Pump Placement for Unresectable Intrahepatic Cholangiocarcinoma.

139. Effect of Sarcopenia on the Increase in Liver Volume and Function After Portal Vein Embolization.

140. Recurrent cholangitis in patients with a non-stenotic hepaticojejunostomy: incidence and risk factors.

141. Nationwide Use and Outcome of Surgery for Locally Advanced Pancreatic Cancer Following Induction Chemotherapy.

142. Preoperative endoscopic biliary drainage by metal versus plastic stents for resectable perihilar cholangiocarcinoma.

143. Current level of shared decision-making in hepatobiliary surgical oncology (SAPACHA).

144. Referral rate of patients with incidental gallbladder cancer and survival: outcomes of a multicentre retrospective study.

145. The Influence of Hepatic Steatosis and Fibrosis on Postoperative Outcomes After Major Liver Resection of Perihilar Cholangiocarcinoma.

146. A nationwide assessment of hepatocellular adenoma resection: Indications and pathological discordance.

147. Nationwide treatment and outcomes of perihilar cholangiocarcinoma.

148. TIGIT and PD1 Co-blockade Restores ex vivo Functions of Human Tumor-Infiltrating CD8 + T Cells in Hepatocellular Carcinoma.

Catalog

Books, media, physical & digital resources